HIV Malignancy Specimens for Research at No Charge
These National Institutes of Health (NIH) Funding Opportunity Announcements (FOA) solicit research to better understand the epidemiology & biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in …
To download a copy of the application form, click here.
The U.S. National Cancer Institute (NCI)-funded AIDS and Cancer Specimen Resource (ACSR) is pleased to announce the release of the Young Investigator Pilot Award (YIPA) for 2021. We welcome applications …
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- …
• Letter of Intent required by December 30, 2020• Proposals must be submitted via e-mail in PDF or MS Word by 5 PM EST, Friday, January 29, 2021 to ssilver@gwu.edu. …
The National Cancer Institute (NCI) and Cancer Research UK (CRUK), the world’s leading funders of cancer research, are partnering to fund the Cancer Grand Challenges (CGC) program. Cancer Grand Challenges …
FOA Number: RFA-CA-20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance …
Notice Number NOT-CA-20-098 Notice of Intent to Publish a Funding Opportunity Announcement for Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) The National Cancer Institute …
Funding Opportunity Announcement (FOA) Number PAR-20-106 The purpose of this Funding Opportunity Announcement (FOA) PAR-20-106 is to invite applications for the Centers for AIDS Research (CFAR) program-to provide administrative and …
Notice Number: NOT-AI-20-034 Key DatesRelease Date: March 25, 2020First Available Due Date: March 25, 2020Expiration Date: March 25, 2021 Related AnnouncementsNOT-AI-20-040PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) …